Loading…
Phenotype of Chronic Obstructive Pulmonary Disease Based on Computed Tomography–Defined Underlying Pathology
Chronic obstructive pulmonary disease (COPD) is a complex and heterogeneous disease. Not all patients with COPD respond to available drugs. Identifying respondents to therapy is critical to delivering the most appropriate treatment and avoiding unnecessary medication. Recognition of individual patie...
Saved in:
Published in: | Tuberculosis and respiratory diseases 2022-10, Vol.85 (4), p.302-312 |
---|---|
Main Author: | |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c430t-5d2f1fcad4750c57d3a11a7d0aa74f0b144d326f85d75e5b25373f7af52a68bb3 |
---|---|
cites | cdi_FETCH-LOGICAL-c430t-5d2f1fcad4750c57d3a11a7d0aa74f0b144d326f85d75e5b25373f7af52a68bb3 |
container_end_page | 312 |
container_issue | 4 |
container_start_page | 302 |
container_title | Tuberculosis and respiratory diseases |
container_volume | 85 |
creator | Kim, Won-Dong |
description | Chronic obstructive pulmonary disease (COPD) is a complex and heterogeneous disease. Not all patients with COPD respond to available drugs. Identifying respondents to therapy is critical to delivering the most appropriate treatment and avoiding unnecessary medication. Recognition of individual patients’ dominant characteristics by phenotype is a useful tool to better understand their disease and tailor treatment accordingly. To look for a suitable phenotype, it is important to understand what makes COPD complex and heterogeneous. The pathology of COPD includes small airway disease and/or emphysema. Thus, COPD is not a single disease entity. In addition, there are two types (panlobular and centrilobular) of emphysema in COPD. The coexistence of different pathological subtypes could be the reason for the complexity and heterogeneity of COPD. Thus, it is necessary to look for the phenotype based on the difference in the underlying pathology. Review of the literature has shown that clinical manifestation and therapeutic response to pharmacological therapy are different depending on the presence of computed tomography–defined airway wall thickening in COPD patients. Defining the phenotype of COPD based on the underlying pathology is encouraging as most clinical manifestations can be distinguished by the presence of increased airway wall thickness. Pharmacological therapy has shown significant effect on COPD with airway wall thickening. However, it has limited use in COPD without an airway disease. The phenotype of COPD based on the underlying pathology can be a useful tool to better understand the disease and adjust treatment accordingly. |
doi_str_mv | 10.4046/trd.2022.0029 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_0574c573841c40a795c48208ed42cb0c</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_0574c573841c40a795c48208ed42cb0c</doaj_id><sourcerecordid>2689053215</sourcerecordid><originalsourceid>FETCH-LOGICAL-c430t-5d2f1fcad4750c57d3a11a7d0aa74f0b144d326f85d75e5b25373f7af52a68bb3</originalsourceid><addsrcrecordid>eNpVkctu1TAQhi0EoofCkn2WbHLwNXY2SHDKpVKlnkW7thxfklSJHWynUna8A2_Ik-DDqZC6mRnNjL5_Rj8A7xHcU0ibjzmaPYYY7yHE7QuwwxCyukGCvgQ7xImoCSPNBXiT0gOEDWmFeA0uCBMYE8R3wB8H60PeFlsFVx2GGPyoq9su5bjqPD7a6rhOc_AqbtXVmKxKtvpSgqmCrw5hXtZc6rswhz6qZdj-_Pp9Zd3oS_PeGxunbfR9dVR5CFPot7fglVNTsu-e8iW4__b17vCjvrn9fn34fFNrSmCumcEOOa0M5Qxqxg1RCCluoFKcOtghSg3BjRPMcGZZhxnhxHHlGFaN6DpyCa7PXBPUg1ziOJcHZFCj_NcIsZcq5lFPVkLGaZEggiJNoeIt01RgKKyhWHdQF9anM2tZu9kabX2OanoGfT7x4yD78CjbclXDRAF8eALE8HO1Kct5TNpOk_I2rEniRrSQEYxYWa3PqzqGlKJ1_2UQlCe_ZfFbnvyWJ7_JX2Nkn-U</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2689053215</pqid></control><display><type>article</type><title>Phenotype of Chronic Obstructive Pulmonary Disease Based on Computed Tomography–Defined Underlying Pathology</title><source>Open Access: PubMed Central</source><creator>Kim, Won-Dong</creator><creatorcontrib>Kim, Won-Dong</creatorcontrib><description>Chronic obstructive pulmonary disease (COPD) is a complex and heterogeneous disease. Not all patients with COPD respond to available drugs. Identifying respondents to therapy is critical to delivering the most appropriate treatment and avoiding unnecessary medication. Recognition of individual patients’ dominant characteristics by phenotype is a useful tool to better understand their disease and tailor treatment accordingly. To look for a suitable phenotype, it is important to understand what makes COPD complex and heterogeneous. The pathology of COPD includes small airway disease and/or emphysema. Thus, COPD is not a single disease entity. In addition, there are two types (panlobular and centrilobular) of emphysema in COPD. The coexistence of different pathological subtypes could be the reason for the complexity and heterogeneity of COPD. Thus, it is necessary to look for the phenotype based on the difference in the underlying pathology. Review of the literature has shown that clinical manifestation and therapeutic response to pharmacological therapy are different depending on the presence of computed tomography–defined airway wall thickening in COPD patients. Defining the phenotype of COPD based on the underlying pathology is encouraging as most clinical manifestations can be distinguished by the presence of increased airway wall thickness. Pharmacological therapy has shown significant effect on COPD with airway wall thickening. However, it has limited use in COPD without an airway disease. The phenotype of COPD based on the underlying pathology can be a useful tool to better understand the disease and adjust treatment accordingly.</description><identifier>ISSN: 1738-3536</identifier><identifier>EISSN: 2005-6184</identifier><identifier>DOI: 10.4046/trd.2022.0029</identifier><identifier>PMID: 35822317</identifier><language>eng</language><publisher>The Korean Academy of Tuberculosis and Respiratory Diseases</publisher><subject>centrilobular emphysema ; chronic obstructive pulmonary disease ; emphysema ; panlobular emphysema ; phenotype ; Review ; small airway disease</subject><ispartof>Tuberculosis and respiratory diseases, 2022-10, Vol.85 (4), p.302-312</ispartof><rights>Copyright © 2022 The Korean Academy of Tuberculosis and Respiratory Diseases 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c430t-5d2f1fcad4750c57d3a11a7d0aa74f0b144d326f85d75e5b25373f7af52a68bb3</citedby><cites>FETCH-LOGICAL-c430t-5d2f1fcad4750c57d3a11a7d0aa74f0b144d326f85d75e5b25373f7af52a68bb3</cites><orcidid>0000-0003-0141-1971</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537658/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537658/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,882,27905,27906,53772,53774</link.rule.ids></links><search><creatorcontrib>Kim, Won-Dong</creatorcontrib><title>Phenotype of Chronic Obstructive Pulmonary Disease Based on Computed Tomography–Defined Underlying Pathology</title><title>Tuberculosis and respiratory diseases</title><description>Chronic obstructive pulmonary disease (COPD) is a complex and heterogeneous disease. Not all patients with COPD respond to available drugs. Identifying respondents to therapy is critical to delivering the most appropriate treatment and avoiding unnecessary medication. Recognition of individual patients’ dominant characteristics by phenotype is a useful tool to better understand their disease and tailor treatment accordingly. To look for a suitable phenotype, it is important to understand what makes COPD complex and heterogeneous. The pathology of COPD includes small airway disease and/or emphysema. Thus, COPD is not a single disease entity. In addition, there are two types (panlobular and centrilobular) of emphysema in COPD. The coexistence of different pathological subtypes could be the reason for the complexity and heterogeneity of COPD. Thus, it is necessary to look for the phenotype based on the difference in the underlying pathology. Review of the literature has shown that clinical manifestation and therapeutic response to pharmacological therapy are different depending on the presence of computed tomography–defined airway wall thickening in COPD patients. Defining the phenotype of COPD based on the underlying pathology is encouraging as most clinical manifestations can be distinguished by the presence of increased airway wall thickness. Pharmacological therapy has shown significant effect on COPD with airway wall thickening. However, it has limited use in COPD without an airway disease. The phenotype of COPD based on the underlying pathology can be a useful tool to better understand the disease and adjust treatment accordingly.</description><subject>centrilobular emphysema</subject><subject>chronic obstructive pulmonary disease</subject><subject>emphysema</subject><subject>panlobular emphysema</subject><subject>phenotype</subject><subject>Review</subject><subject>small airway disease</subject><issn>1738-3536</issn><issn>2005-6184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkctu1TAQhi0EoofCkn2WbHLwNXY2SHDKpVKlnkW7thxfklSJHWynUna8A2_Ik-DDqZC6mRnNjL5_Rj8A7xHcU0ibjzmaPYYY7yHE7QuwwxCyukGCvgQ7xImoCSPNBXiT0gOEDWmFeA0uCBMYE8R3wB8H60PeFlsFVx2GGPyoq9su5bjqPD7a6rhOc_AqbtXVmKxKtvpSgqmCrw5hXtZc6rswhz6qZdj-_Pp9Zd3oS_PeGxunbfR9dVR5CFPot7fglVNTsu-e8iW4__b17vCjvrn9fn34fFNrSmCumcEOOa0M5Qxqxg1RCCluoFKcOtghSg3BjRPMcGZZhxnhxHHlGFaN6DpyCa7PXBPUg1ziOJcHZFCj_NcIsZcq5lFPVkLGaZEggiJNoeIt01RgKKyhWHdQF9anM2tZu9kabX2OanoGfT7x4yD78CjbclXDRAF8eALE8HO1Kct5TNpOk_I2rEniRrSQEYxYWa3PqzqGlKJ1_2UQlCe_ZfFbnvyWJ7_JX2Nkn-U</recordid><startdate>20221001</startdate><enddate>20221001</enddate><creator>Kim, Won-Dong</creator><general>The Korean Academy of Tuberculosis and Respiratory Diseases</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-0141-1971</orcidid></search><sort><creationdate>20221001</creationdate><title>Phenotype of Chronic Obstructive Pulmonary Disease Based on Computed Tomography–Defined Underlying Pathology</title><author>Kim, Won-Dong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c430t-5d2f1fcad4750c57d3a11a7d0aa74f0b144d326f85d75e5b25373f7af52a68bb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>centrilobular emphysema</topic><topic>chronic obstructive pulmonary disease</topic><topic>emphysema</topic><topic>panlobular emphysema</topic><topic>phenotype</topic><topic>Review</topic><topic>small airway disease</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kim, Won-Dong</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals (DOAJ)</collection><jtitle>Tuberculosis and respiratory diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kim, Won-Dong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phenotype of Chronic Obstructive Pulmonary Disease Based on Computed Tomography–Defined Underlying Pathology</atitle><jtitle>Tuberculosis and respiratory diseases</jtitle><date>2022-10-01</date><risdate>2022</risdate><volume>85</volume><issue>4</issue><spage>302</spage><epage>312</epage><pages>302-312</pages><issn>1738-3536</issn><eissn>2005-6184</eissn><abstract>Chronic obstructive pulmonary disease (COPD) is a complex and heterogeneous disease. Not all patients with COPD respond to available drugs. Identifying respondents to therapy is critical to delivering the most appropriate treatment and avoiding unnecessary medication. Recognition of individual patients’ dominant characteristics by phenotype is a useful tool to better understand their disease and tailor treatment accordingly. To look for a suitable phenotype, it is important to understand what makes COPD complex and heterogeneous. The pathology of COPD includes small airway disease and/or emphysema. Thus, COPD is not a single disease entity. In addition, there are two types (panlobular and centrilobular) of emphysema in COPD. The coexistence of different pathological subtypes could be the reason for the complexity and heterogeneity of COPD. Thus, it is necessary to look for the phenotype based on the difference in the underlying pathology. Review of the literature has shown that clinical manifestation and therapeutic response to pharmacological therapy are different depending on the presence of computed tomography–defined airway wall thickening in COPD patients. Defining the phenotype of COPD based on the underlying pathology is encouraging as most clinical manifestations can be distinguished by the presence of increased airway wall thickness. Pharmacological therapy has shown significant effect on COPD with airway wall thickening. However, it has limited use in COPD without an airway disease. The phenotype of COPD based on the underlying pathology can be a useful tool to better understand the disease and adjust treatment accordingly.</abstract><pub>The Korean Academy of Tuberculosis and Respiratory Diseases</pub><pmid>35822317</pmid><doi>10.4046/trd.2022.0029</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0003-0141-1971</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1738-3536 |
ispartof | Tuberculosis and respiratory diseases, 2022-10, Vol.85 (4), p.302-312 |
issn | 1738-3536 2005-6184 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_0574c573841c40a795c48208ed42cb0c |
source | Open Access: PubMed Central |
subjects | centrilobular emphysema chronic obstructive pulmonary disease emphysema panlobular emphysema phenotype Review small airway disease |
title | Phenotype of Chronic Obstructive Pulmonary Disease Based on Computed Tomography–Defined Underlying Pathology |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T20%3A49%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phenotype%20of%20Chronic%20Obstructive%20Pulmonary%20Disease%20Based%20on%20Computed%20Tomography%E2%80%93Defined%20Underlying%20Pathology&rft.jtitle=Tuberculosis%20and%20respiratory%20diseases&rft.au=Kim,%20Won-Dong&rft.date=2022-10-01&rft.volume=85&rft.issue=4&rft.spage=302&rft.epage=312&rft.pages=302-312&rft.issn=1738-3536&rft.eissn=2005-6184&rft_id=info:doi/10.4046/trd.2022.0029&rft_dat=%3Cproquest_doaj_%3E2689053215%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c430t-5d2f1fcad4750c57d3a11a7d0aa74f0b144d326f85d75e5b25373f7af52a68bb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2689053215&rft_id=info:pmid/35822317&rfr_iscdi=true |